AACI Update | February 2021

Headlines

Ronai Named Director of Sanford Burnham Prebys' Cancer Center

Ronai Named Director of Sanford Burnham Prebys' Cancer Center

Renowned cancer researcher Ze’ev Ronai, PhD, has been named director of Sanford Burnham Prebys Medical Discovery Institute's National Cancer Institute (NCI)-Designated Cancer Center. Dr. Ronai's research in cancer biology has focused on the rewiring of signal transduction pathways, which has led to novel scientific paradigms and formed the basis for clinical trials to treat malignancies. As director, Dr. Ronai will play a central role in coordinating basic science across the research programs to translate scientific findings into new approaches for cancer prevention, diagnosis, and treatment.

Read More

Pioneering Clinical Investigator Simone Dies

Pioneering Clinical Investigator Simone Dies

Joseph V. Simone, MD, a pioneering clinical investigator and institutional leader in pediatric oncology, died January 21 at the age of 85, according to the American Society of Clinical Oncology (ASCO). Among his many leadership roles, Dr. Simone served as president of the Association of American Cancer Institutes (1992-1993), and served on the boards of directors for ASCO and the American Association for Cancer Research (AACR).

Read More

Rustgi Joins AACI Board of Directors

Rustgi Joins AACI Board of Directors

Anil K. Rustgi, MD, has joined AACI's Board of Directors. Dr. Rustgi was named director of Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center in 2019. He is also Irving Professor of Medicine; associate dean of oncology; and chief of cancer services. He was appointed to complete the term of Charles S. Fuchs, MD, MPH, director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital, Yale School of Medicine. Dr. Fuchs was named senior vice president and global head of product development for oncology and hematology at Roche and Genentech.

Read More

AACI Applauds Biden/Harris Inauguration, Readies for Renewed Federal Focus on Cancer

AACI Applauds Biden/Harris Inauguration, Readies for Renewed Federal Focus on Cancer

AACI congratulated President Joe Biden and Vice President Kamala Harris on their inauguration and pledged its strong support of their efforts to end the COVID-19 pandemic and promote cancer research, treatment, and prevention. The association formed a strong bond with President Biden during his leadership of President Barack Obama’s Cancer Moonshot initiative.

Read More

AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health

AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health

AACI is collaborating with the U.S. Department of Health & Human Services as part of its Vaccine Consultation Panel (VCP). Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.

Read More

Save the Date: AACI/AACR Virtual Hill Day

Save the Date: AACI/AACR Virtual Hill Day

AACI will jointly host its annual Hill Day with the American Association for Cancer Research (AACR) on Wednesday, June 9. The event will be held virtually for the second year. All faculty and staff of AACI cancer centers are invited to spend the day advocating for cancer research funding. 

Read More

13th Annual CRI Meeting Moves to Virtual Format; Abstract Submissions Now Open

13th Annual CRI Meeting Moves to Virtual Format; Abstract Submissions Now Open

The 13th Annual AACI CRI Meeting will be held virtually July 13-15. The three-day online meeting will deliver the innovative, quality education that AACI members have enjoyed at prior CRI annual meetings. The CRI Steering Committee is currently soliciting abstracts for the meeting, which will will focus on adapting cancer clinical research for 2021 and beyond.

Read More

Champion for Cures Nominations Due February 8

AACI cancer center directors are invited to submit nominations for the 2021 Champion for Cures Award by Monday, February 8. Selected by the AACI Board of Directors, the awardee will have gained distinction through their visionary approach to promoting our shared goal of a future without cancer. Through their transformational philanthropy, the cancer center can focus beyond immediate needs to multiply its impact on patient health, research, and the surrounding community.

Read More

News from the Centers

Chen Named Rowley Professor in Cancer Research

Chen Named Rowley Professor in Cancer Research
The University of Chicago Medicine Comprehensive Cancer Center

Jing Chen, PhD, an international leader in cancer metabolism, was recently named the first Janet Davison Rowley Professor in Cancer Research. Dr. Chen also serves as inaugural director of the newly established Cancer Metabolic Research Center.

Read More

Baumann Named to Four Cancer Advisory Committees

Baumann Named to Four Cancer Advisory Committees
Siteman Cancer Center

Brian C. Baumann, MD, a radiation oncologist, has been chosen to serve on four national cancer advisory committees: National Association for Proton Therapy Physician Advisory Committee; National Cancer Institute Bladder Cancer Task Force; NRG Oncology Genitourinary Committee; and the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology Committee.

Read More

Cancer Center Members Named to National Breast Cancer Clinical Trials Task Force

The University of Kansas Cancer Center

Jamie Wagner, DO, FACOS, FACS, and Shane Stecklein, MD, PhD, have been appointed to the Breast Oncology Local Disease Task Force of the National Cancer Institute Breast Cancer Steering Committee. Their three-year terms began January 1.

Read More

V Foundation Awards Two Huntsman Researchers

V Foundation Awards Two Huntsman Researchers
Huntsman Cancer Institute, University of Utah

Two researchers at Huntsman Cancer Institute at the University of Utah have received awards from the V Foundation for Cancer Research. Charles R. Rogers, PhD, MPH, MS, was awarded the 2020 V Scholar Grant, and Jennifer Doherty, PhD, MS, received the 2020 Robin Roberts Cancer Thrivership Research Award.

Read More

Abstract Named 2020 Best of ASTRO

Abstract Named 2020 Best of ASTRO
University of Florida Health Cancer Center

The American Society for Radiation Oncology (ASTRO) Best of ASTRO Program Committee has selected an abstract by Raymond Mailhot Vega, MD, MPH, as a 2020 Best of ASTRO abstract.

Read More

Swartz Elected to the National Academy of Medicine

Swartz Elected to the National Academy of Medicine
The University of Chicago Medicine Comprehensive Cancer Center

Melody Swartz, PhD, has been elected a member of the National Academy of Medicine. She was honored for "pioneering contributions" to the fields of lymphatic physiology, cancer research, and immunotherapy.

Read More

Back to News From the Centers

Grant Aims to Apply Artificial Intelligence to Oral Cancer Treatment

Vanderbilt-Ingram Cancer Center

Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence to help customize treatment for oral cancer patients.

Read More

Cancer Metastasis is Target of New Research Initiative

UCSF Helen Diller Family Comprehensive Cancer Center

Six UC San Francisco researchers have won a $3 million "Endeavor Award" to build a new research collaborative at the university focused on decoding the "rulebook" of metastatic cancer as a pathway to new treatments. The Mark Foundation for Cancer Research established the awards to support research challenges that are too far-reaching for a single lab to address.

Read More

Back to News From the Centers

Brain Tumor Expert Appointed as New Deputy Director of Research

Brain Tumor Expert Appointed as New Deputy Director of Research
UPMC Hillman Cancer Center

UPMC Hillman Cancer Center recently announced the appointment of Jeremy Rich, MD, MHS, MBA, as deputy director of research. Dr. Rich will also serve as the Pittsburgh Foundation Chair in Personalized Cancer Therapy and a professor of neurology at the University of Pittsburgh School of Medicine.

Read More

Greenup Appointed Chief of Breast Surgical Oncology

Greenup Appointed Chief of Breast Surgical Oncology
Yale Cancer Center, Yale School of Medicine

Rachel Adams Greenup, MD, MPH, FACS, has been appointed as associate professor of surgery (oncology) and section chief of breast surgery for the Department of Surgery at Yale School of Medicine. She joins Yale from Duke University.

Read More

Sekeres Named New Physician Liaison in Hematology

Sekeres Named New Physician Liaison in Hematology
Sylvester Comprehensive Cancer Center, University of Miami Health System

Mikkael Sekeres, MD, MS, has joined the Sylvester Comprehensive Cancer Center team as the new physician liaison in hematology and chief of the Division of Hematology in the Department of Medicine.

Read More

D'Amico Named AATS Medical Director

D'Amico Named AATS Medical Director
Duke Cancer Institute, Duke University Medical Center

Thomas A. D’Amico, MD, chief of General Thoracic Surgery and director of the Thoracic Oncology program at Duke Cancer Institute, has been appointed to a two-year term as medical director of the American Association for Thoracic Surgery (AATS).

Read More

Associate Director of Cancer Health Equity and Community Engagement Named

Associate Director of Cancer Health Equity and Community Engagement Named
Stanford Cancer Institute

Alyce Adams, PhD, has been named the inaugural associate director of Stanford Cancer Institute’s Office of Cancer Health Equity and Community Engagement. Her research focuses primarily on the determinants of suboptimal use of health care services among older adults with chronic conditions; racial differences in medication adherence; and the impact of health policy changes on access to quality care.

Read More

Chief Nursing Officer and Vice President of Nursing and Patient Services Named

Chief Nursing Officer and Vice President of Nursing and Patient Services Named
Fox Chase Cancer Center, Temple Health

Fox Chase Cancer Center announces the recruitment of Anna Liza Rodriguez, MSN, MHA, RN, OCN®, NEA-BC, as chief nursing officer and vice president of nursing and patient services. She served for nearly five years as associate nursing officer at Vanderbilt-Ingram Cancer Center before joining Fox Chase.

Read More

Rogers Named Director of Kentucky Cancer Program

Rogers Named Director of Kentucky Cancer Program
UK Markey Cancer Center

UK Markey Cancer Center has announced the appointment of Mindy Rogers as director of the Kentucky Cancer Program – East, which is housed within the cancer center.

Read More

City of Hope Taps First Chief Diversity, Equity, and Inclusion Officer

City of Hope Taps First Chief Diversity, Equity, and Inclusion Officer
City of Hope Comprehensive Cancer Center

Angela L. Talton has joined City of Hope's executive leadership team as senior vice president and chief diversity, equity, and inclusion officer.

Read More

New Chief of Hematology and Oncology Announced

New Chief of Hematology and Oncology Announced
Hollings Cancer Center, Medical University of South Carolina

Craig Lockhart, MD, has been recruited as the new chief of the Division of Hematology & Oncology at the Medical University of South Carolina and will serve as associate director for clinical science at MUSC Hollings Cancer Center, effective April 1. Dr. Lockhart currently holds several roles at the University of Miami Sylvester Comprehensive Cancer Center.

Read More

Davis to Lead Health Data Science and AI

University of Colorado Cancer Center

Sean Davis, MD, PhD, who currently serves as a senior associate scientist at the National Cancer Institute, will serve as the new associate director for informatics and data science at the University of Colorado Cancer Center.

Read More

Chief of Blood Cancer Pathology Service Named

Chief of Blood Cancer Pathology Service Named
Duke Cancer Institute, Duke University Medical Center

Ken H. Young, MD, PhD, is the new chief of the Hematopathology Division and Duke Cancer Institute Blood Cancer Pathology Service. He directs a lab focused on the mechanisms of tumor progression and novel therapeutic strategies in lymphoma, myeloma, and leukemia. Dr. Young joined Duke in 2019 from The University of Texas MD Anderson Cancer Center.

Read More

Kim to Direct Women's Cancer Program

Kim to Direct Women's Cancer Program
Cedars-Sinai Cancer

Internationally prominent gynecologic oncologist Kenneth H. Kim, MD, recently was selected to direct the Division of Gynecologic Oncology at Cedars-Sinai Cancer. He also serves as chair of the cancer center's Committee for Oversight of Training and Education.

Read More

Helmke is New Chief Operating Officer

Helmke is New Chief Operating Officer
Fox Chase Cancer Center, Temple Health

Fox Chase Cancer Center announces the addition of Joel Helmke, MSHP, FACHE, to its senior leadership team as chief operating officer. Before joining Fox Chase, Helmke served nearly five years as senior vice president of clinical operations at City of Hope National Medical Center.

Read More

Hinrichs Named to Build Cancer Immunology and Immunotherapy Programs

Hinrichs Named to Build Cancer Immunology and Immunotherapy Programs
Rutgers Cancer Institute of New Jersey

Christian Hinrichs, MD, has been named chief of the Section of Cancer Immunotherapy and co-director of the Cancer Immunology and Metabolism Center of Excellence. Dr. Hinrichs was recruited from the National Cancer Institute where he served as a tenured senior investigator in the Genitourinary Malignancies Branch.

Read More

New Director for Cell Therapy Laboratory Announced

UPMC Hillman Cancer Center

UPMC Hillman Cancer Center has announced that Yen-Michael Hsu, MD, PhD, will serve as the new director of the Immunologic Monitoring and Cellular Therapeutics Laboratory.

Read More

Back to News From the Centers

Gut Microbe May Promote Breast Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

A microbe found in the colon and commonly associated with the development of colitis and colon cancer also may play a role in the development of some breast cancers, according to new research from investigators with the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Read More

Proteogenomics Offers Insight to Treating Head and Neck Squamous Cell Carcinoma

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer. A new study identifies three molecular subtypes in head and neck squamous cell carcinoma that could be used to better determine appropriate treatment. The research was led by Baylor College of Medicine, Johns Hopkins University, and the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium.

Read More

Gene Sequencing Used to Quantify Risk of Skin Cancer Long Before Damage is Visible

Roswell Park Comprehensive Cancer Center

Research conducted by a team at Roswell Park Comprehensive Cancer Center sheds light on the carcinogenic effect of exposure to ultraviolet (UV) radiation. A new study details a method to measure the abundance of cancer-related early changes to skin tissue long before the damage becomes visible to the eye.

Read More

Aggressive Breast Cancers in Black Patients Related to Immune Factors

Roswell Park Comprehensive Cancer Center

Rates of death from breast cancer are 40 percent higher in Black women than in white women. Research shows the tumors in Black women are more aggressive, but experts did not know why. New research from Roswell Park shows the aggressive cancer is related to a greater number of "exhausted" immune cells.

Read More

Machine Learning Potential to Predict Cancer Therapy-Related Cardiac Risk Shown

Case Comprehensive Cancer Center

Machine learning-based approaches to risk assessment can be highly effective in predicting various types of cardiac dysfunction among cancer survivors who have received cardiotoxic cancer therapies, according to a new retrospective longitudinal study by researchers from Cleveland Clinic’s Lerner Research Institute; Heart, Vascular & Thoracic Institute; and Taussig Cancer Institute.

Read More

Unique Review of National Data Aims to Better Understand Geographic Factors Affecting HPV Vaccination Rates

Unique Review of National Data Aims to Better Understand Geographic Factors Affecting HPV Vaccination Rates
VCU Massey Cancer Center

Bernard Fuemmeler, PhD, and his team have conducted the first-ever systematic review of area-level data reported in the United States between 2006 and 2020 to determine how geography, neighborhoods, and sociodemographic factors impact HPV vaccination rates among adolescents and young adults.

Read More

Older Minority Cancer Patients Have Worse Surgical Outcomes Compared to White Patients With Similar Socioeconomic Factors

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Older minority cancer patients with poor social determinants of health are significantly more likely to experience negative surgical outcomes compared to white patients with similar risk factors, according to a new study published by researchers at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute.

Read More

Researchers Create Comprehensive Multiomic Resource for Head and Neck Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins, and signaling pathways in these cancers.

Read More

Understanding Kava's Role as a Cancer Suppressant

Understanding Kava's Role as a Cancer Suppressant
University of Florida Health Cancer Center

If there’s one piece of advice Chengguo "Chris" Xing, PhD, would give you, it’s to "stress less." Dr. Xing, a UF Health Cancer Center member, sees stress as the culprit in various health conditions: insomnia, anxiety, tobacco cravings — even cancer. He’s been evaluating piper methysticum, better known as kava, for its potential to help manage all of these.

Read More

Unusual Colon Discovery Explains Racial Disparities in Colorectal Cancer

University of Virginia Cancer Center

The colons of African Americans and people of European descent age differently, new research reveals. Scientists at the University of Virginia found that one side of the colon ages biologically faster than the other in both African Americans and people of European descent. In African Americans, however, the right side ages significantly faster, explaining why African Americans are more likely to develop cancerous lesions on the right side and why they are more likely to suffer colorectal cancer at a younger age.

Read More

Inflammation From Androgen Deprivation Therapy May Cause Fatigue in Prostate Cancer Patients

Moffitt Cancer Center

Moffitt Cancer Center researchers are investigating whether inflammation in the body, a side effect of androgen deprivation therapy, contributes to symptoms such as fatigue, depression, and cognitive impairment in prostate cancer patients. In a new study they pinpoint a specific inflammation marker that is associated with increased fatigue in this group of patients.

Read More

Mediterranean Diet May Decrease Risk of Prostate Cancer Progression for Men on Active Surveillance

The University of Texas MD Anderson Cancer Center

Examining a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.

Read More

Key Pathway for Activated T Cells Might Be Targeted to Fight GVHD

University of Michigan Rogel Cancer Center

A new understanding of intracellular pathways activated as T cells start to mount an immune response offers clues against graft-versus-host disease, a serious complication of bone marrow transplantation.

Read More

Investigational Combo Therapy Shows Benefit for TP53 Mutant MDS and Acute Myeloid Leukemia Patients

Investigational Combo Therapy Shows Benefit for TP53 Mutant MDS and Acute Myeloid Leukemia Patients
Moffitt Cancer Center

David Sallman, MD, is leading a national, multicenter clinical trial investigating a new therapy option for patients with TP53-mutant disease. It builds upon the standard of care therapy, combining eprenetapopt with the chemotherapy azacitidine. Eprenetapopt is a first-in-class mutant p53 reactivator. It is infused in the body and induces cell death in TP53 mutant cancer cells.

Read More

Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

UK Markey Cancer Center

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

Read More

Youth Using E-cigarettes Three Times as Likely to Become Daily Cigarette Smokers

UC San Diego Moores Cancer Center

An analysis of a large nationally representative longitudinal study reports that starting tobacco products, including e-cigarettes, before the age of 18 is a major risk factor for people becoming daily cigarette smokers.

Read More

Arthritis Drug May Treat Immunotherapy-Related Heart Complication

Vanderbilt-Ingram Cancer Center

A drug typically prescribed for rheumatoid arthritis may also be effective in treating a rare but potentially deadly heart complication some cancer patients experience after taking immunotherapies, according to a study co-led by investigators at Vanderbilt University Medical Center.

Read More

'Biological Clock' an Unexpected and Novel Target for Prostate Cancer

Sidney Kimmel Cancer Center at Jefferson Health

Studies have shown that when circadian rhythms are disturbed there is an increased incidence of some cancers including prostate cancer. With an urgent need to develop novel therapeutic targets for prostate cancer, researchers at the Sidney Kimmel Cancer at Jefferson Health explored the circadian clock and found an unexpected role for the clock gene CRY-1 in cancer progression.

Read More

Findings Could Reduce Treatment-Related Complication for Blood Cancer Patients

Findings Could Reduce Treatment-Related Complication for Blood Cancer Patients
Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center published promising findings on preventing a common complication to lifesaving blood stem cell transplantation in leukemia. Sherif Farag, MD, PhD, found that using a drug approved for type 2 diabetes reduces the risk of acute graft-versus-host disease.

Read More

Study Defines Small-Cell Lung Cancer Subtypes and Distinct Therapeutic Vulnerabilities for Each Type

The University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center have developed the first comprehensive framework to classify small-cell lung cancer into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type.

Read More

Study Explains Why Patients With Cancer Spread to the Liver Have Worse Outcomes

Study Explains Why Patients With Cancer Spread to the Liver Have Worse Outcomes
University of Michigan Rogel Cancer Center

Michael Green, MD, PhD, noticed that when his patients had cancer that spread to the liver, they fared worse than when cancer spread to other parts of the body – and immunotherapy treatments had little impact. A new study finds that tumors in the liver siphon off critical immune cells, rendering immunotherapy ineffective. But coupling immunotherapy with radiotherapy to the liver in mice restored the immune cell function.

Read More

Study Reveals How Improved Type of Light Therapy Kills Precancerous Cells

Case Comprehensive Cancer Center

Researchers in the Department of Biomedical Engineering at Cleveland Clinic Lerner Research Institute have developed an improved approach to treating actinic keratosis, a precancerous skin condition usually treated with photodynamic therapy that patients often report as painful.

Read More

Triggering Tumor Antiviral Immune Response in Triple Negative Breast Cancer

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers to trigger tumor cell death and signal the body’s immune response.

Read More

Back to News From the Centers

Tobacco Treatment Training Program Earns Elite Accreditation

Tobacco Treatment Training Program Earns Elite Accreditation
The University of Kansas Cancer Center

The University of Kansas Tobacco Treatment Specialist training program has been accredited by the Council for Tobacco Treatment Training Programs, joining just 23 other such accredited programs in the world. Babalola Faseru, MD, MPH, helps lead the program.

Read More

Community Advisory Board: Champions for Health Equity

Community Advisory Board: Champions for Health Equity
UCSF Helen Diller Family Comprehensive Cancer Center

Over the past 15 years, the cancer center’s Community Advisory Board (CAB) has become one of UCSF’s most instrumental community outreach groups for improving health equity. In a Q&A, CAB Chair Arnold Perkins and Kim Rhoads, MD, MS, MPH, discuss why CABs are critical to the work of NCI cancer centers and the communities they serve.

Read More

Fourth Affiliate Joins Siteman Cancer Network

Siteman Cancer Center

The Siteman Cancer Network, an affiliation between Siteman Cancer Center and regional medical centers, has added a fourth member, the network’s second in Illinois. Carterville-based SIH Cancer Institute has joined the network, which aims to improve the health of people and communities through cancer prevention, research, and access to specialized treatment, when necessary, at Siteman in St. Louis.

Read More

Back to News From the Centers

Cancer Center Jobs

Chief, Division of Hematology and Medical Oncology
The Tisch Cancer Institute at Mount Sinai
Read more
Vanderbilt-Incyte Research Scholars Program
Vanderbilt-Ingram Cancer Center
Read more
Clinical Research Coordinator IV
Winship Cancer Institute of Emory University
Read more
Senior Analyst Programmer OnCore Support Team
Wilmot Cancer Institute, UR Medicine
Read more
Senior Business Process Analyst
Fred Hutchinson Cancer Research Center
Read more
Senior Vice President for External Affairs
Dana-Farber Cancer Institute, Harvard Medical School
Read more

Funding Opportunities

AACR Cancer Disparities Research Fellowships

Deadline: February 9, 2021

This grant program pertains to the following fellowships:

  • AACR-Bristol Myers Squibb Cancer Disparities Research Fellowship
  • AACR-Genentech Cancer Disparities Research Fellowship

Grant recipients must attend the Annual Grant Awards Event to formally accept their grant. The grantees will be contacted regarding arrangements. Grant funds may be used to support the grantees’ registration and attendance at this meeting. In the event of unforeseen scheduling changes, the grantee will be contacted regarding alternative arrangements.

More Information

Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research

Deadline: February 11, 2021
The Lustgarten Foundation and the American Association for Cancer Research (AACR) have established two new career development awards for early-career female and underrepresented pancreatic cancer researchers, representing a generous commitment of the Lustgarten Foundation of up to $1.8 million. The awards will honor the extraordinary lives and legacies of United States Supreme Court Justice Ruth Bader Ginsburg and civil rights icon and 17-term Georgia Congressman John Robert Lewis, two influential and inspiring public figures who died of pancreatic cancer in 2020.
More Information

Meeting Announcements

Cancer Disparities Symposium

March 4, 2021
Virtual Meeting

Navigating Cancer Disparities: Lessons Learned and How to Move Forward

The Case Comprehensive Cancer Center Office of Community Outreach and Engagement is pleased to present the 5th Annual Cancer Disparities Symposium, "Navigating Cancer Disparities: Lessons Learned and How to Move Forward."

This multidisciplinary event will appeal to researchers, clinicians, health professionals, community outreach groups, community-based organizations, patient advocates, and trainees.

Session topics include:

  • COVID-19 and cancer disparities
  • Improving the participation of minority and underserved populations in cancer clinical trials
  • Interplay of biology and social determinants of cancer disparities
  • The many pains of cancer: physical, emotional and financial

Attendees will have the opportunity to participate in an in-depth discussion of the book Just Medicine: A Cure for Racial Inequality in American Health Care by Dayna Bowen Matthew.

Participants will use the Whova web-based conference app to view presentations and ask questions in real-time and network with others behind the scenes.

Learn More
Back to top